Oral contraceptives, menopausal hormone therapy use and risk of B‐cell non‐Hodgkin lymphoma in the California Teachers Study
Authors:
- Yani LuYLYani Lu
- James V. LaceyJLJames V. Lacey
Open Access
- 18 October 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 129 (4) , 974-982
Abstract
We examined oral contraceptive (OC) and menopausal hormonal therapy (MHT) use in relation to risk of B‐cell non‐Hodgkin lymphoma (NHL). Women under age 85 years participating in the California Teachers Study with no history of hematopoietic cancer were followed from 1995 through 2007. A total of 516 of 114,131 women eligible for OC use analysis and 402 of 54,758 postmenopausal women eligible for MHT use analysis developed B‐cell NHL. Multivariable adjusted and age stratified Cox proportional hazards models were fit to estimate relative risks (RRs) and 95% confidence intervals (95% CI). Ever versus never OC use was marginally associated with lower B‐cell NHL risk, particularly among women first using OCs before age 25 years (RR = 0.72, 95% CI = 0.51–0.99); yet, no duration‐response effect was observed. No association was observed for ever versus never MHT use among postmenopausal women (RR = 1.05, 95% CI = 0.83–1.33) overall or by formulation (estrogen alone, ET, or estrogen plus progestin, EPT). Among women with no MHT use, having bilateral oophorectomy plus hysterectomy was associated with greater B‐cell NHL risk than having natural menopause (RR = 3.15, 95% CI = 1.62–6.13). Bilateral oophorectomy plus hysterectomy was not associated with risk among women who used ET or EPT. These results indicate that exogenous hormone use does not strongly influence B‐cell NHL risk.Keywords
This publication has 29 references indexed in Scilit:
- Combined Hormone Therapy at Menopause and Breast Cancer: A Warning—Short-Term Use Increases RiskJournal of Clinical Oncology, 2009
- Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health‐AARP Diet and Health Study CohortInternational Journal of Cancer, 2009
- Non-Hodgkin Lymphoma in Women: Reproductive Factors and Exogenous Hormone UseAmerican Journal of Epidemiology, 2008
- Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish Population-based Cohort StudyBritish Journal of Cancer, 2006
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001Blood, 2006
- Polymorphisms and Haplotypes in the Cytochrome P450 17A1, Prolactin, and Catechol-O-Methyltransferase Genes and Non-Hodgkin Lymphoma RiskCancer Epidemiology, Biomarkers & Prevention, 2005
- Menstrual and Reproductive Factors and Risk of Non-Hodgkin's Lymphoma among Connecticut WomenAmerican Journal of Epidemiology, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Early B‐lymphocyte precursors and their regulation by sex steroidsImmunological Reviews, 2000
- Influence of oral contraceptive therapy on the activity of systemic lupus erythematosusArthritis & Rheumatism, 1982